Literature DB >> 29533100

Successful outcome for patients with streptococcal prosthetic joint infections - a retrospective population-based study.

Anny Lam1, Magnus Rasmussen2, Olof Thompson2.   

Abstract

BACKGROUND/AIM: Streptococci cause approximately 10% of prosthetic joint infections (PJIs). The aim of this study was to identify the characteristics of patients with streptococcal PJIs and to describe the treatment and outcome of streptococcal PJIs in Skåne county between 2011 and 2015.
METHODS: Patients with streptococcal PJIs with positive cultures or PCRs on samples from joint aspirate and/or periprosthetic tissue between 2011 and 2015 in Skåne county, were identified and medical records were studied.
RESULTS: Eighty-three PJI episodes treated at seven hospitals were identified. The median age was 70 years (IQR: 64-78) and there were more men (61%) than women. Hip joints were the most common site of isolation (54%). The most frequently isolated pathogens were beta-haemolytic streptococci of groups A, C and G (31%), group B (30%), and alpha-haemolytic streptococci (23%). Overall failure rate was 11% (n = 9), and lack of comorbidity was significantly associated with a favourable outcome. The most common treatment strategy was debridement, antibiotic treatment and implant retention (DAIR) (n = 64; 77%) and the initial success rate using this strategy was 84% (n = 53).
CONCLUSION: This study indicates an acceptable success rate for the patients treated with DAIR strategy, and a high overall success rate for episodes suffering streptococcal PJIs.

Entities:  

Keywords:  Biofilm; Implant retention; Prosthetic joint infection; Streptococcus

Mesh:

Substances:

Year:  2018        PMID: 29533100     DOI: 10.1080/23744235.2018.1449961

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  5 in total

1.  Hair of the Dog? Periprosthetic Joint Infection with Streptococcus can is.

Authors:  Andrew McGuire; Nicole Krysa; Steve Mann
Journal:  Arthroplast Today       Date:  2021-02-27

Review 2.  Risk factors affect success rate of debridement, antibiotics and implant retention (DAIR) in periprosthetic joint infection.

Authors:  Yihong Xu; Liping Wang; Weidong Xu
Journal:  Arthroplasty       Date:  2020-12-07

3.  Reactive Thrombocytosis Leading to Recurrent Arterial Thrombosis Reversed by Management of a Prosthetic Joint Infection of the Hip.

Authors:  Matthias Papen; Stijn Ghijselings; Georges Vles
Journal:  Cureus       Date:  2022-04-15

4.  A population-based study on the treatment and outcome of enterococcal prosthetic joint infections. A consecutive series of 55 cases.

Authors:  Olof Thompson; Magnus Rasmussen; Anna Stefánsdóttir; Bertil Christensson; Per Åkesson
Journal:  J Bone Jt Infect       Date:  2019-11-07

5.  In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection.

Authors:  Mariana Albano; Melissa J Karau; Kerryl E Greenwood-Quaintance; Douglas R Osmon; Caitlin P Oravec; Daniel J Berry; Matthew P Abdel; Robin Patel
Journal:  Microbiol Spectr       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.